Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model

<b>Background/Objectives</b>: <i>Helicobacter pylori</i> is the leading cause of chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosal-associated lymphoma. Due to the emerging problems with antibiotic treatment against <i>H. pylori</i> in clinical p...

Full description

Saved in:
Bibliographic Details
Main Authors: Rita Amaral, Tomás Concha, Jorge Vítor, António J. Almeida, Cecília Calado, Lídia M. Gonçalves
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/17/1/132
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587693938180096
author Rita Amaral
Tomás Concha
Jorge Vítor
António J. Almeida
Cecília Calado
Lídia M. Gonçalves
author_facet Rita Amaral
Tomás Concha
Jorge Vítor
António J. Almeida
Cecília Calado
Lídia M. Gonçalves
author_sort Rita Amaral
collection DOAJ
description <b>Background/Objectives</b>: <i>Helicobacter pylori</i> is the leading cause of chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosal-associated lymphoma. Due to the emerging problems with antibiotic treatment against <i>H. pylori</i> in clinical practice, <i>H. pylori</i> vaccination has gained more interest. Oral immunization is considered a promising approach for preventing initial colonization of this bacterium in the gastrointestinal tract, establishing a first line of defense at gastric mucosal surfaces. Chitosan nanoparticles can be exploited effectively for oral vaccine delivery due to their stability, simplicity of target accessibility, and beneficial mucoadhesive and immunogenic properties. <b>Methods</b>: In this study, new multi-epitope pDNA- and recombinant protein-based vaccines incorporating multiple <i>H. pylori</i> antigens were produced and encapsulated in chitosan nanoparticles for oral and intramuscular administration. The induced immune response was assessed through the levels of antigen-specific IgGs, secreted mucosal SIgA, and cytokines (IL-2, IL-10, and IFN-γ) in immunized BALB/C mice. <b>Results</b>: Intramuscular administration of both pDNA and recombinant protein-based vaccines efficiently stimulated the production of specific IgG2a and IgG1, which was supported by cytokines levels. Oral immunizations with either pDNA or recombinant protein vaccines revealed high SIgA levels, suggesting effective gastric mucosal immunization, contrasting with intramuscular immunizations, which did not induce SIgA. <b>Conclusions</b>: These findings indicate that both pDNA and recombinant protein vaccines encapsulated into chitosan nanoparticles are promising candidates for eradicating <i>H. pylori</i> and mitigating associated gastric diseases in humans.
format Article
id doaj-art-1e1b506fe7c34f969bb8d5b150285936
institution Kabale University
issn 1999-4923
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-1e1b506fe7c34f969bb8d5b1502859362025-01-24T13:46:05ZengMDPI AGPharmaceutics1999-49232025-01-0117113210.3390/pharmaceutics17010132Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse ModelRita Amaral0Tomás Concha1Jorge Vítor2António J. Almeida3Cecília Calado4Lídia M. Gonçalves5Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, PortugalResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, PortugalResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, PortugalResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, PortugalISEL—Instituto Superior de Engenharia de Lisboa, Instituto Politécnico de Lisboa, 1959-007 Lisbon, PortugalResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal<b>Background/Objectives</b>: <i>Helicobacter pylori</i> is the leading cause of chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosal-associated lymphoma. Due to the emerging problems with antibiotic treatment against <i>H. pylori</i> in clinical practice, <i>H. pylori</i> vaccination has gained more interest. Oral immunization is considered a promising approach for preventing initial colonization of this bacterium in the gastrointestinal tract, establishing a first line of defense at gastric mucosal surfaces. Chitosan nanoparticles can be exploited effectively for oral vaccine delivery due to their stability, simplicity of target accessibility, and beneficial mucoadhesive and immunogenic properties. <b>Methods</b>: In this study, new multi-epitope pDNA- and recombinant protein-based vaccines incorporating multiple <i>H. pylori</i> antigens were produced and encapsulated in chitosan nanoparticles for oral and intramuscular administration. The induced immune response was assessed through the levels of antigen-specific IgGs, secreted mucosal SIgA, and cytokines (IL-2, IL-10, and IFN-γ) in immunized BALB/C mice. <b>Results</b>: Intramuscular administration of both pDNA and recombinant protein-based vaccines efficiently stimulated the production of specific IgG2a and IgG1, which was supported by cytokines levels. Oral immunizations with either pDNA or recombinant protein vaccines revealed high SIgA levels, suggesting effective gastric mucosal immunization, contrasting with intramuscular immunizations, which did not induce SIgA. <b>Conclusions</b>: These findings indicate that both pDNA and recombinant protein vaccines encapsulated into chitosan nanoparticles are promising candidates for eradicating <i>H. pylori</i> and mitigating associated gastric diseases in humans.https://www.mdpi.com/1999-4923/17/1/132<i>Helicobacter pylori</i>vaccineDNA vaccineimmunizationrecombinant antigens
spellingShingle Rita Amaral
Tomás Concha
Jorge Vítor
António J. Almeida
Cecília Calado
Lídia M. Gonçalves
Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
Pharmaceutics
<i>Helicobacter pylori</i>
vaccine
DNA vaccine
immunization
recombinant antigens
title Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
title_full Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
title_fullStr Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
title_full_unstemmed Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
title_short Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
title_sort chitosan nanoparticles for enhanced immune response and delivery of multi epitope i helicobacter pylori i vaccines in a balb c mouse model
topic <i>Helicobacter pylori</i>
vaccine
DNA vaccine
immunization
recombinant antigens
url https://www.mdpi.com/1999-4923/17/1/132
work_keys_str_mv AT ritaamaral chitosannanoparticlesforenhancedimmuneresponseanddeliveryofmultiepitopeihelicobacterpyloriivaccinesinabalbcmousemodel
AT tomasconcha chitosannanoparticlesforenhancedimmuneresponseanddeliveryofmultiepitopeihelicobacterpyloriivaccinesinabalbcmousemodel
AT jorgevitor chitosannanoparticlesforenhancedimmuneresponseanddeliveryofmultiepitopeihelicobacterpyloriivaccinesinabalbcmousemodel
AT antoniojalmeida chitosannanoparticlesforenhancedimmuneresponseanddeliveryofmultiepitopeihelicobacterpyloriivaccinesinabalbcmousemodel
AT ceciliacalado chitosannanoparticlesforenhancedimmuneresponseanddeliveryofmultiepitopeihelicobacterpyloriivaccinesinabalbcmousemodel
AT lidiamgoncalves chitosannanoparticlesforenhancedimmuneresponseanddeliveryofmultiepitopeihelicobacterpyloriivaccinesinabalbcmousemodel